RachelERauMD

Pediatric Hematology & Oncology • Seattle, WA

Associate Professor, Pediatrics, University of Washington/Seattle Children’s Hospital

Join to view full profile

Dr. Rau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rau's full profile

Already have an account?

Office
4800 Sand Point Way NE
Suite 1220
Seattle, WA 98105
Phone+1 206-884-4464

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2010
Johns Hopkins UniversityResidency, Pediatrics, 2003 - 2006
Ohio State University College of MedicineClass of 2003

Certifications & Licensure

WA State Medical License 2023 - 2026
TX State Medical License 2012 - 2024
MD State Medical License 2006 - 2013
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

9 citations
Constitutive loss of DNMT3A causes morbid obesity through misregulation of adipogenesis.
Ayala Tovy, Jaime M Reyes, Linda Zhang, Yung-Hsin Huang, Carina Rosas
Elife. 2022-05-30
14 citations
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
Ayala Tovy, Carina Rosas, Amos Gaikwad, Geraldo Medrano, Linda Zhang
Haematologica. 2021-06-03
333 citations
DNMT3A in haematological malignancies.
Liubin Yang, Rachel E. Rau, Margaret A. Goodell
Nature Reviews. Cancer. 2015-03-01

Abstracts/Posters

Targeting Activated Signaling Pathways for the Treatment of IKZF1-Deleted B Lymphoblastic Leukemia
Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens (RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or...
Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Novel Short Latency, High Penetrance Model of KRAS Mutation-Driven T-Cell Acute Lymphoblastic Leukemia
Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Mosaic DNMT3A Germline Mutation As a Model for Mutant DNMT3A Competitive Advantage in the Blood Lineage
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Prognostic Factors in Acute Lymphoblastic LeukemiaJanuary 31st, 2020